Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
KORTUC INC. logo — Revolutionzing Cancer Radiotherapy by the cutting edge techn...

KORTUC INC.

Revolutionzing Cancer Radiotherapy by the cutting edge technology from Japan.

Founded 2015 United States Palo Alto, United States 3 employees Series A Total: $21.00M Biotechnology, Health Care +1

General Information

Company Name KORTUC INC.
Founded Year 2015
Location United States Palo Alto, United States
Employees 3
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series A
Business Model B2B, B2B2C
Revenue Model Product Sales, Licensing, Tiered Pricing
Social

BounceWatch is an independent company data service, not affiliated with KORTUC INC.. To contact KORTUC INC., visit kortuc.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does KORTUC INC. compare?

A PDF of KORTUC INC. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting KORTUC INC. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About KORTUC INC.

KORTUC INC., founded in 2015, is a trailblazer in the Biotechnology, Health Care, and Pharmaceutical industries. The company is headquartered in the United States and is renowned for its innovative approach to enhancing the efficacy of cancer treatments.

With its slogan, "Revolutionizing Cancer Radiotherapy by the cutting-edge technology from Japan," KORTUC INC. introduces a groundbreaking drug that utilizes Hydrogen Peroxide injections into tumors. This method significantly elevates the sensitivity of tumors to radiotherapy, addressing the fundamental challenge of making radiotherapy more potent and effective.

The company's potential was acknowledged through a substantial $21.00M Series A investment completed on 01 May 2021. This underscores investor confidence and provides a solid foundation for further development and market penetration.

Business keywords: cancer radiotherapy, innovative drug, hydrogen peroxide injection, tumor sensitivity, radiotherapy enhancement, radio-sensitizing platform, cancer treatment technology, multi-indication therapy, radiation effectiveness, immunotherapy enhancement, oncology innovation, tumor targeting, therapeutic innovation, healthcare advancement

Services & Products

Development of Innovative Radiosensitizers
Enhancing Effectiveness of Cancer Radiotherapy
Research Collaboration in Oncology

Target Customers

Oncologists Radiotherapy Centers Medical Researchers Healthcare Professionals

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $21.00M -
01 May 2021

KORTUC INC. Alternatives & Competitors

View All Alternatives
KORTUC INC. vs
ViewRay, Inc.
ViewRay, Inc. United States

Conquer cancer by re-envisioning radiation therapy.

Post-IPO Debt
76 employees
Biotechnology, Health Care
KORTUC INC. vs
Abdera Therapeutics
Abdera Therapeutics United States

Abdera Therapeutics Inc. is a precision oncology company developing next-generation targeted radiati...

Series B
36 employees
Biotechnology, Health Care
Compare KORTUC INC. vs Abdera Therapeutics
KORTUC INC. vs
Forty Seven Inc.
Forty Seven Inc. United States

Helping Patients Defeat Their Cancer

Post-IPO Equity
17 employees
Biotechnology, Health Care
View all alternatives

FAQ About KORTUC INC.

Revolutionzing Cancer Radiotherapy by the cutting edge technology from Japan.
KORTUC INC. was founded in 2015.
KORTUC INC. is headquartered in Palo Alto, United States.
KORTUC INC. operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on cancer radiotherapy, innovative drug, hydrogen peroxide injection and tumor sensitivity. Its customers include Oncologists, Radiotherapy Centers and Medical Researchers.
KORTUC INC. has a B2B and B2B2C business model. Its revenue comes from Product Sales, Licensing and Tiered Pricing.
KORTUC INC. has approximately 3 employees.
KORTUC INC. has completed 1 funding round, raising a total of $21.00M. The latest funding stage is Series A.
KORTUC INC. offers: Development of Innovative Radiosensitizers, Enhancing Effectiveness of Cancer Radiotherapy, Research Collaboration in Oncology.
Top alternatives and competitors to KORTUC INC. include ViewRay, Inc., Abdera Therapeutics, Forty Seven Inc., Shasqi, Aktis Oncology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
KORTUC INC. and ViewRay, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for KORTUC INC., https://bouncewatch.com/company/kortuc-inc, updated 5 April 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout